Archives

  • MEDICAL TIMES. Volume 1. Issue 1. 2023
    Vol. 1 No. 1 (2023)

    This journal issue focuses on advancements in reproductive medicine, particularly in addressing both male and female fertility challenges through innovative clinical practices and cutting-edge research. It brings together key studies on recurrent pregnancy loss, biochemical pregnancies, and the role of thyroid function in fertility. Special attention is given to reproductive risks in patients aged 35 and above, as well as chromosomal anomalies in couples facing recurrent miscarriage.

    Innovative therapeutic strategies include supercharged stromal-cell transfer for fertility treatment, metabolic therapies for male infertility, and immunotherapy for improving IVF outcomes. The issue also highlights rehabilitation methods for pelvic floor dysfunction, offering comprehensive insights into improving fertility outcomes and addressing complex reproductive health issues.

  • MEDICAL TIMES. Volume 2. Issue 1. 2024
    Vol. 2 No. 1 (2024)

    The journal issue focuses on advancements in reproductive medicine, particularly in assisted reproductive technologies (ART), in vitro fertilization (IVF), and related areas of fertility and reproductive health. It brings together an array of research studies, clinical reviews, and innovative approaches from international experts in the field, with a strong emphasis on both male and female fertility challenges.

    Key topics include the use of artificial intelligence (AI) in IVF, genetic polymorphisms affecting pregnancy outcomes, and the impact of conditions such as polycystic ovary syndrome (PCOS) and endometriosis on fertility. Several articles explore innovative therapeutic strategies, such as metabolic treatments for male infertility, regenerative therapies for endometrial health, and stem cell therapy in reproductive medicine.

    Overall, the journal offers comprehensive insights into the latest scientific advances and clinical practices aimed at improving fertility outcomes, addressing recurrent implantation failure, and optimizing IVF techniques to tackle both common and rare fertility challenges faced by patients.

  • MEDICAL TIMES. Volume 3. Issue 1. 2025
    Vol. 3 No. 1 (2025)

    A dedicated peer-reviewed journal was published as part of the 20th World Congress on Human Reproduction, showcasing a curated selection of original research articles, clinical studies, and case reports from leading experts in the field. The journal reflects the scientific depth and diversity of the congress, with contributions addressing some of the most critical and emerging challenges in reproductive medicine today. Topics ranged from recurrent implantation failure, HPV-related intraepithelial neoplasia, and infertility in oncology patients, to advanced strategies for egg donor preparation, PRP and exosome use in poor responders, and hormonal management during pregnancy. This diverse range of topics is intended to enrich and broaden the understanding of our audience. Several articles explored broader issues such as gestational diabetes, allergies in pregnancy, menopause-related vitamin D deficiency, and the psychological dimensions of sexual health. The publication featured work by authors from Georgia, Armenia, Ukraine, Kazakhstan, Russia, and beyond, highlighting both regional insights and international standards of care. Notably, the journal included a landmark article on IVF laboratory safety and error prevention spanning two decades. This scientific collection, a lasting academic contribution of the congress, offers clinicians, researchers, and healthcare professionals not just theoretical knowledge but also valuable perspectives and practical tools. These tools, derived from the latest research and clinical studies, can be applied to improve reproductive outcomes for women worldwide, especially in the context of advanced maternal age.